成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 154350-29-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 154350-29-5
Chemical Structure| 154350-29-5
Structure of 154350-29-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 154350-29-5 ]

Related Doc. of [ 154350-29-5 ]

Alternatived Products of [ 154350-29-5 ]
Product Citations

Product Details of [ 154350-29-5 ]

CAS No. :154350-29-5 MDL No. :MFCD08705286
Formula : C3H7NO2S Boiling Point : No data available
Linear Structure Formula :- InChI Key :WMSPXQIQBQAWLL-UHFFFAOYSA-N
M.W : 121.16 Pubchem ID :15765418
Synonyms :

Calculated chemistry of [ 154350-29-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 26.09
TPSA : 68.54 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.04
Log Po/w (XLOGP3) : -0.52
Log Po/w (WLOGP) : 0.46
Log Po/w (MLOGP) : -1.35
Log Po/w (SILICOS-IT) : -0.55
Consensus Log Po/w : -0.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.2
Solubility : 76.9 mg/ml ; 0.634 mol/l
Class : Very soluble
Log S (Ali) : -0.45
Solubility : 42.9 mg/ml ; 0.354 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.0
Solubility : 122.0 mg/ml ; 1.0 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.42

Safety of [ 154350-29-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 154350-29-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 154350-29-5 ]

[ 154350-29-5 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 154350-29-5 ]
  • tert-butyl ((2R,6S,13aS,14aR,16aS,Z)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-2-((3-(thiophen-2-yl)quinoxalin-2-yl)oxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl)carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
71% The title compound from Example 2 (21.0 mg, 0.031 mmol) and carbonyldiimidazole (6.0 mg, 0.037 mmol) were dissolved in 0.7 ml anhydrous DMF and the resulting solution was heated to 40 C. for 1 hour. Cyclopropylsulfonamide (8.0 mg, 0.06 mmol) was added to the reaction followed by DBU (7.0 mg, 0.046 mmol). The reaction mixture was stirred at 40 C. for 10 hour. LCMS showed the formation of the desired product. The reaction was cooled down and 10 ml ethyl acetate was added to the solution. The mixture was washed with saturated aqueous NaHCO3 solution, water and brine. The organic layer was dried over anhydrous sodium sulfate. The organic phase was then filtered, concentrated in vacuo and subsequently purified by flash chromatography (ethyl acetate/hexanes 1:1) to give 17.0 mg (71%) of the title compound. MS (ESI) m/z 779.2 (M+H)+. 1H-NMR (500 MHz, CD3Cl): δ 10.24 (1H, s), 8.10 (1H, s), 8.00 (1H, d, J=8.0 Hz), 7.82 (1H, d, J=8.0 Hz), 7.60 (2H, m), 7.49 (1H, d, J=5.0 Hz), 7.16 (1H, s), 6.91 (1H, s), 6.09 (1H, s), 5.67 (1H, m), 5.12 (1H, m), 4.98 (1H, t, J=8.0 Hz), 4.70 (1H, t, J=8.0 Hz), 4.62 (2H, s), 4.33 (1H, m), 4.10 (1H, m), 2.92 (1H, m), 2.75 (2H, m), 2.58 (2H, m), 2.28 (1H, m), 1.91 (2H, m), 1.60-0.80 (20H, m). 13C-NMR (125 MHz, CD3Cl, 200-40 ppm region): δ 177.1, 173.5, 168.1, 155.2, 152.5, 140.7, 139.8, 139.1, 136.5, 130.5, 130.4, 129.7, 128.7, 128.3, 127.6, 127.1, 124.8, 80.1, 75.8, 59.7, 53.5, 52.3, 44.8.
  • 2
  • [ 154350-29-5 ]
  • Cyclopropanesulfonic acid 4-[(R)-4-(7-methoxy-1-oxo-3,4-dihydro-1H-isoquinolin-2-ylmethyl)-2,5-dioxo-imidazolidin-4-ylethynyl]-benzoylamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
48% Example 1570 Compound 1570 A was prepared from Compound 400 and 4-iodobenzoic acid by sequential application of the procedures given in Parts H and I in Example 400. Solid carbonyl diimidazole (19 mg, 0.12 mmol) was added in one portion to a stirred solution of Compound 1570A in THF (200 mL). The solution was stirred at 70 0C for 1.5 h, and was subsequently allowed to cool to rt. Solid <strong>[154350-29-5]cyclopropanesulfonamide</strong> (17 mg, 0.14 mmol) and DBU (43 mL, 43 mg, 0.29 mmol) were added sequentially and the reaction mixture was stirred at rt for 18 h. The solvent was evaporated and the residue was dissolved in DCM (50 mL). The solution was washed sequentially with 0.1 N aq hydrochloric acid (~25 mL), water (~25 mL) and brine (~25 mL). The organic phase was dried over anhydrous MgSCM, filtered and concentrated under reduced pressure to afford an off-white solid. The crude product was purified by PTLC (3:1 EtOAc-hexanes + 1% HCO2H) to afford the desired Compound 1570 (24 mg, 48% yield) as a beige solid.
  • 3
  • [ 154350-29-5 ]
  • C41H50N6O8S [ No CAS ]
YieldReaction ConditionsOperation in experiment
51% The title compound from Example 2 (2c) (6.0 mg, 0.01 mmol) and carbonyldiimidazole (2.0 mg, 0.01 mmol) were dissolved in 0.75 ml anhydrous DMF and the resulting solution was heated to 40 0C for 1 h. Cyclopropylsulfonamide (3.6 mg, 0.03 mmol) was added to the reaction followed by DBU (4.5 mg, 0.03 mmol). The reaction mixture was stirred at 40 0C, until completion was confirmed by MS analysis. The reaction was diluted with 10 ml ethyl acetate and extracted with saturated aqueous with NaHCO3 (2 x 2 mL) and brine (1 x 2 mL). The organic phase was dried over anhydrous Na2SO4, filtered, and then concentrated in vacuo. The residue was purified by silica gel flash chromatography using gradient elution with MeOH in DCM (1%→2%→5%) affording affording pyridazinone 4a. (4.0 mg, 51 %) MS (ESI) m/z = 787.3 (M+H)+.
  • 4
  • [ 154350-29-5 ]
  • C38H46N6O8S3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
51% The title compound from Example 2 (6.0 mg) and carbonyldiimidazole (2.0 mg) were dissolved in 0.75 ml anhydrous DMF and the resulting solution was heated to 40 0C for 1 h. Cyclopropylsulfonamide (3.6 mg) was added to the reaction followed by DBU (4.5 mg). The reaction mixture was stirred at 40 0C, until completion was confirmed by MS analysis. The reaction was diluted with 10 ml ethyl acetate and extracted with saturated aqueous with NaHCCh (2 x 2 mL) and brine (1 x 2 mL). The organic phase was dried over anhydrous Na2SO4, filtered, and then concentrated in vacuo. The residue was purified by silica gel flash chromatography using gradient elution with MeOH in DCM (1%- >2%- >5%) affording the title compound. (4.0 mg, 51 %) MS (ESI) m/z = 811.42 (M+H)+.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 154350-29-5 ]

Simeprevir Intermediates

Chemical Structure| 1703-58-8

[ 1703-58-8 ]

Butane-1,2,3,4-tetracarboxylic acid

Related Functional Groups of
[ 154350-29-5 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 669008-26-8

[ 669008-26-8 ]

1-Methylcyclopropane-1-sulfonamide

Similarity: 0.88

Chemical Structure| 2438-38-2

[ 2438-38-2 ]

Cyclohexanesulfonamide

Similarity: 0.85

Chemical Structure| 445305-93-1

[ 445305-93-1 ]

Cyclopropylmethanesulfonamide

Similarity: 0.79

Chemical Structure| 630421-42-0

[ 630421-42-0 ]

N-(tert-Butyl)cyclopropanesulfonamide

Similarity: 0.66

Chemical Structure| 669008-25-7

[ 669008-25-7 ]

N-(tert-Butyl)-1-methylcyclopropane-1-sulfonamide

Similarity: 0.62

Amines

Chemical Structure| 669008-26-8

[ 669008-26-8 ]

1-Methylcyclopropane-1-sulfonamide

Similarity: 0.88

Chemical Structure| 24243-71-8

[ 24243-71-8 ]

Propane-1-sulfonamide

Similarity: 0.86

Chemical Structure| 81363-76-0

[ 81363-76-0 ]

Propane-2-sulfonamide

Similarity: 0.86

Chemical Structure| 2438-38-2

[ 2438-38-2 ]

Cyclohexanesulfonamide

Similarity: 0.85

Chemical Structure| 445305-93-1

[ 445305-93-1 ]

Cyclopropylmethanesulfonamide

Similarity: 0.79

Sulfamides

Chemical Structure| 669008-26-8

[ 669008-26-8 ]

1-Methylcyclopropane-1-sulfonamide

Similarity: 0.88

Chemical Structure| 24243-71-8

[ 24243-71-8 ]

Propane-1-sulfonamide

Similarity: 0.86

Chemical Structure| 81363-76-0

[ 81363-76-0 ]

Propane-2-sulfonamide

Similarity: 0.86

Chemical Structure| 2438-38-2

[ 2438-38-2 ]

Cyclohexanesulfonamide

Similarity: 0.85

Chemical Structure| 445305-93-1

[ 445305-93-1 ]

Cyclopropylmethanesulfonamide

Similarity: 0.79

; ;